We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
UK biotech firm Vernalis said it was raising a net 27.6 million pounds ($52.7
million) in a share sale to start a business in North America, buy new products
and develop its experimental medicines.
Kyowa Hakko Kogyo has announced that it will dissolve a distribution partnership
with Janssen Pharmaceutical for Itrizole Capsule, an oral antimycological agent,
as of the end of March.
Eisai Co. Ltd. has announced that it has established a pharmaceuticals marketing
subsidiary, Eisai S.r.l. (Eisai Societa a responsabilita limitata) in Italy
on Feb. 21.
Japanese drugmaker Sankyo Co. unveiled plans on Friday
to buy Daiichi Pharmaceutical in October in a deal worth $7.7 billion, accelerating
a shakeup in the world's second-largest pharmaceuticals market.
Two House Democrats have introduced legislation that would hold pharmaceutical
executives criminally liable when they fail to disclose evidence of serious
adverse events related to their products.
The FDA has launched a web-based User Fee System that is integrated with the
agency's accounting system, through which customers can create and submit Form
FDA 3397, agency officials announced at the Drug Information Association's Electronic
Document Management Conference in Philadelphia.
On the heels of a recent workshop on follow-on biologics,
the Generic Pharmaceutical Association (GPhA) is again encouraging the FDA to
create an abbreviated approval pathway for generic biologics
Any pharmaceutical importation plan that fixes the terms of trade is equivalent
to importing price controls, which could endanger the future of drug innovation
and limit access to new drugs, according to the head of the Senate health panel.
Prolexys Pharmaceuticals, a biopharmaceutical company dedicated to the development
of novel cancer therapies, has signed an exclusive licensing agreement with
the Massachusetts Institute of Technology, acting as licensing agent for the
Whitehead Institute for Biomedical Research of Cambridge, Mass., and Columbia
University of New York City.